These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 28107179

  • 1. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.
    Kumar B, Yadav A, Brown NV, Zhao S, Cipolla MJ, Wakely PE, Schmitt AC, Baiocchi RA, Teknos TN, Old M, Kumar P.
    Oncotarget; 2017 Feb 28; 8(9):14847-14859. PubMed ID: 28107179
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.
    Lin RJ, Lubpairee T, Liu KY, Anderson DW, Durham S, Poh CF.
    J Otolaryngol Head Neck Surg; 2013 Mar 19; 42(1):23. PubMed ID: 23672832
    [Abstract] [Full Text] [Related]

  • 6. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J, Wald T, Kuhnt T, Gradistanac T, Kolb M, Dietz A, Wiegand S, Wichmann G.
    Cancer; 2020 Jan 01; 126(9):1856-1872. PubMed ID: 32032442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS, Ryu J, Cho KH, Choi MK, Moon SH, Yun T, Chun BS, Lee GK, Ahn HJ, Lee JH, Vermeer P, Jung YS.
    Head Neck; 2012 Oct 01; 34(10):1408-17. PubMed ID: 22052559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Sobande FA, Ryska A.
    Neoplasma; 2012 Oct 01; 59(4):398-408. PubMed ID: 22489695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L, Datta N, Renkonen S, Atula T, Mäkitie A, Haglund C, Ahmed A, Syrjänen S, Grénman R, Auvinen E, Lehtonen S, Hagström J.
    Tumour Biol; 2015 Sep 01; 36(10):7755-64. PubMed ID: 25941114
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, Imai Y, Usami Y.
    Jpn J Clin Oncol; 2014 Mar 01; 44(3):232-40. PubMed ID: 24470584
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma.
    Lai S, Wenaas AE, Sandulache VC, Hartman C, Chiao E, Kramer J, Zevallos JP.
    Ann Clin Lab Sci; 2016 Mar 01; 46(2):132-9. PubMed ID: 27098618
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.